GSK3B and schizophrenia: Conversely, other reports detected no changes in GSK-3β mRNA levels in blood cells obtained from first-episode schizophrenia patients, and the levels of the protein were actually low in the frontal cortex and CSF of schizophrenia subjects (Kozlovsky et al., 2001; Zhang et al., 2021).